Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome

Irritable bowel syndrome (IBS) has been associated with microbial dysbiosis.

[1]  O. Gilja,et al.  Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study , 2019, Gut.

[2]  V. Anttila,et al.  Minor Effect of Antibiotic Pre-treatment on the Engraftment of Donor Microbiota in Fecal Transplantation in Mice , 2019, Front. Microbiol..

[3]  Mimi Y. Kim,et al.  Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial. , 2019, The lancet. Gastroenterology & hepatology.

[4]  T. Dinan,et al.  Mood and Microbes: Gut to Brain Communication in Depression. , 2019, Gastroenterology clinics of North America.

[5]  M. Zamani,et al.  Systematic review with meta‐analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome , 2019, Alimentary pharmacology & therapeutics.

[6]  M. Surette,et al.  Gut Microbiota in Patients With Irritable Bowel Syndrome-A Systematic Review. , 2019, Gastroenterology.

[7]  T. Hausken,et al.  Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS) , 2019, Nutrients.

[8]  W. D. de Vos,et al.  The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study , 2019, Clinical and translational gastroenterology.

[9]  J. Andrews,et al.  Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial , 2019, JAMA.

[10]  U. Ghoshal,et al.  Rome Foundation Working Team Report on Post-Infection Irritable Bowel Syndrome. , 2019, Gastroenterology.

[11]  F. Ryan,et al.  Long-term colonisation with donor bacteriophages following successful faecal microbial transplantation , 2018, Microbiome.

[12]  P. Moayyedi,et al.  Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome , 2018, Alimentary pharmacology & therapeutics.

[13]  L. Hansen,et al.  Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study , 2018, Gut.

[14]  L. Marciani,et al.  Demonstration of differences in colonic volumes, transit, chyme consistency, and response to psyllium between healthy and constipated subjects using magnetic resonance imaging , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[15]  K. Korpela,et al.  Intestinal microbiota development and gestational age in preterm neonates , 2018, Scientific Reports.

[16]  V. Anttila,et al.  The long‐term effects of faecal microbiota transplantation for gastrointestinal symptoms and general health in patients with recurrent Clostridium difficile infection , 2018, Alimentary pharmacology & therapeutics.

[17]  P. Valle,et al.  Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. , 2018, The lancet. Gastroenterology & hepatology.

[18]  M. Surette,et al.  Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome. , 2017, Gastroenterology.

[19]  N. Bhala,et al.  Systematic review with meta‐analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection , 2017, Alimentary pharmacology & therapeutics.

[20]  M. Kamm,et al.  Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial , 2017, The Lancet.

[21]  N. Maharshak,et al.  Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature , 2017, Digestive Diseases and Sciences.

[22]  Rémi Brazeilles,et al.  Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome. , 2017, Gastroenterology.

[23]  W. D. de Vos,et al.  Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection , 2016, BMC Medicine.

[24]  T. Dinan,et al.  A gut (microbiome) feeling about the brain , 2016, Current opinion in gastroenterology.

[25]  A. Colville,et al.  Adverse events in faecal microbiota transplant: a review of the literature. , 2016, The Journal of hospital infection.

[26]  R. Spiller,et al.  Irritable bowel syndrome , 2015, Nature Reviews Disease Primers.

[27]  A. Salonen,et al.  Microbial signatures in post-infectious irritable bowel syndrome – toward patient stratification for improved diagnostics and treatment , 2015, Gut microbes.

[28]  P. Enck,et al.  Placebo effects and their determinants in gastrointestinal disorders , 2015, Nature Reviews Gastroenterology &Hepatology.

[29]  M. Surette,et al.  Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. , 2015, Gastroenterology.

[30]  Jeroen Raes,et al.  Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates , 2015, Gut.

[31]  C. Manichanh,et al.  Intestinal Microbiota And Diet in IBS: Causes, Consequences, or Epiphenomena? , 2015, The American Journal of Gastroenterology.

[32]  R. Satokari,et al.  Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrent Clostridium difficile infection – an observational cohort study , 2015, Alimentary pharmacology & therapeutics.

[33]  T. Dinan,et al.  Bifidobacteria exert strain‐specific effects on stress‐related behavior and physiology in BALB/c mice , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[34]  M. Leboyer,et al.  Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis , 2014, European Archives of Psychiatry and Clinical Neuroscience.

[35]  K. Garsed,et al.  Faecal microbiota composition and host–microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome , 2013, Gut.

[36]  P. Moayyedi,et al.  Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. , 2013, Gastroenterology.

[37]  V. Anttila,et al.  Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. , 2012, Gastroenterology.

[38]  W. Chey,et al.  The Efficacy and Safety of Rifaximin for the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis , 2012, The American Journal of Gastroenterology.

[39]  Aleksandar Milosavljevic,et al.  Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. , 2011, Gastroenterology.

[40]  W. D. de Vos,et al.  Intestinal Microbiota in Healthy Adults: Temporal Analysis Reveals Individual and Common Core and Relation to Intestinal Symptoms , 2011, PloS one.

[41]  Janne Nikkilä,et al.  Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: effective recovery of bacterial and archaeal DNA using mechanical cell lysis. , 2010, Journal of microbiological methods.

[42]  H. Sintonen,et al.  Health-related quality of life in inflammatory bowel disease measured with the generic 15D instrument , 2010, Quality of Life Research.

[43]  M. Färkkilä,et al.  Gastrointestinal complaints among subjects with depressive symptoms in the general population , 2008, Alimentary pharmacology & therapeutics.

[44]  N. Van Rooijen,et al.  Suppression of experimental colitis by intestinal mononuclear phagocytes , 2006, Journal of leukocyte biology.

[45]  D. Drossman,et al.  Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire , 2000, American Journal of Gastroenterology.

[46]  A. Beck,et al.  Use of the Beck Anxiety and Depression Inventories for Primary Care with Medical Outpatients , 1997, Assessment.

[47]  P. Whorwell,et al.  The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress , 1997, Alimentary pharmacology & therapeutics.